AI
COGT icon

Atom Investors’s Cogent Biosciences COGT Stock Holding History

Atom Investors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Sell
65,281
-22,395
-26% -$784K 0.22% 119
2026
Q1 		$3.37M Buy
87,676
+69,568
+384% +$2.57M 0.24% 133
2025
Q4 		$643K Buy
+18,108
New +$509K 0.05% 368
2025
Q1 		– Sell
-14,277
Closed -$111K – 530
2024
Q4 		$111K Buy
+14,277
New +$142K 0.01% 447
2024
Q3 		– Sell
-23,174
Closed -$195K – 487
2024
Q2 		$195K Sell
23,174
-17,308
-43% -$131K 0.02% 429
2024
Q1 		$272K Sell
40,482
-62,734
-61% -$388K 0.03% 427
2023
Q4 		$607K Buy
103,216
+65,818
+176% +$504K 0.11% 247
2023
Q3 		$365K Buy
37,398
+24,104
+181% +$286K 0.08% 287
2023
Q2 		$157K Sell
13,294
-10,152
-43% -$116K 0.06% 257
2023
Q1 		$253K Sell
23,446
-60,898
-72% -$779K 0.14% 173
2022
Q4 		$975K Buy
84,344
+47,382
+128% +$587K 0.49% 54
2022
Q3 		$551K Sell
36,962
-42,799
-54% -$587K 0.19% 142
2022
Q2 		$719K Sell
79,761
-35,667
-31% -$243K 0.31% 92
2022
Q1 		$865K Buy
115,428
+54,068
+88% +$377K 0.4% 59
2021
Q4 		$526K Buy
+61,360
New +$533K 0.09% 159

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Atom Investors's COGT Position: Q2 2026 in Review

Atom Investors reduced its Cogent Biosciences (COGT) stake by 26% in Q2 2026, selling an estimated $784K and leaving 65,281 shares worth $2.53M. The position accounts for 0.22% of the portfolio, ranked #119.

Atom Investors first reported a position in COGT in Q4 2021 and has held it in 15 quarters since. The position peaked at $3.37M in Q1 2026. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Atom Investors held 65,281 shares of Cogent Biosciences worth $2.53M as of Q2 2026.
  • Atom Investors sold 22,395 Cogent Biosciences shares in Q2 2026, an estimated $784K.
  • Cogent Biosciences made up 0.22% of Atom Investors's portfolio in Q2 2026, its #119 holding.
  • Atom Investors first reported a position in Cogent Biosciences in Q4 2021 and has held it in 15 quarters since.
  • Atom Investors's Cogent Biosciences position peaked at $3.37M in Q1 2026.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.